206 related articles for article (PubMed ID: 22733221)
1. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
[TBL] [Abstract][Full Text] [Related]
2. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
4. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
6. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
[TBL] [Abstract][Full Text] [Related]
7. Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
[TBL] [Abstract][Full Text] [Related]
8. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
[TBL] [Abstract][Full Text] [Related]
9. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
[TBL] [Abstract][Full Text] [Related]
10. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
11. Survival of women with inflammatory breast cancer: a large population-based study.
Dawood S; Lei X; Dent R; Gupta S; Sirohi B; Cortes J; Cristofanilli M; Buchholz T; Gonzalez-Angulo AM
Ann Oncol; 2014 Jun; 25(6):1143-51. PubMed ID: 24669011
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
Gudina AT; Copeland G; Soliman AS; Hirko KA
Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
[TBL] [Abstract][Full Text] [Related]
15. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
16. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
17. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
[TBL] [Abstract][Full Text] [Related]
19. Affluence and Breast Cancer.
Lehrer S; Green S; Rosenzweig KE
Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
